Effects of tenofovir alafenamide combined with pegylated interferon on clinical symptoms and renal function indicators in patients with chronic hepatitis B.
Chronic hepatitis B (CHB) can progress to cirrhosis and liver can-cer. Although antiviral therapy is standard, monotherapy has limitations. This ret-rospective study evaluated the efficacy of tenofovir alafenamide fumarate (TMF) combined with pegylated interferon (Peg-IFNα2b) in 220 CHB patients treated from June 2021...